Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancer

NCT00052169 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

NETWORK

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: ZD1839 in combination with docetaxel

Sponsor

NSABP Foundation Inc

Collaborators

[object Object]